Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imke Metz

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Brain Pathology (Zurich, Switzerland)|May 19, 2010
Wallerian degeneration: a major component of early axonal pathology in multiple sclerosisTomasz Dziedzic, Imke Metz, Tobias Dallenga, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 21, 2018
Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MSFranziska Scheibe, Imke Metz, Helena Radbruch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 3, 2016
Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawalCatherine Larochelle, Imke Metz, Marc-André Lécuyer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2016
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive caseSven Jarius, Imke Metz, Fatima Barbara König, et al.
Annals of Neurology|October 5, 2012
Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debateWolfgang Brück, Bogdan Popescu, Claudia F Lucchinetti, et al.
Acta Neuropathologica|June 20, 2015
Cell type-specific Nrf2 expression in multiple sclerosis lesionsSimon Licht-Mayer, Isabella Wimmer, Sarah Traffehn, et al.
Journal of the Neurological Sciences|February 7, 2018
CLIPPERS with longitudinally extensive transverse myelitis: Role of T versus B cellsDavid G Olmes, Imke Metz, De-Hyung Lee, et al.
Free Neuropathology|October 20, 2023
Serum neurofilament light chains in progressive multiple sclerosis patients treated with repeated cycles of high-dose intravenous steroidsLidia Stork, Michael Haupts, Niels Kruse, et al.
Case Reports in Neurological Medicine|December 21, 2016
Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to FingolimodTim Sinnecker, Jalal Othman, Marc Kühl, et al.
Neurology|June 24, 2018
Drug reaction with eosinophilia and systemic symptoms after daclizumab therapySebastian Rauer, Lidia Stork, Horst Urbach, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Brain Pathology (Zurich, Switzerland)|May 19, 2010
Wallerian degeneration: a major component of early axonal pathology in multiple sclerosisTomasz Dziedzic, Imke Metz, Tobias Dallenga, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 21, 2018
Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MSFranziska Scheibe, Imke Metz, Helena Radbruch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 3, 2016
Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawalCatherine Larochelle, Imke Metz, Marc-André Lécuyer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2016
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive caseSven Jarius, Imke Metz, Fatima Barbara König, et al.
Annals of Neurology|October 5, 2012
Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debateWolfgang Brück, Bogdan Popescu, Claudia F Lucchinetti, et al.
Acta Neuropathologica|June 20, 2015
Cell type-specific Nrf2 expression in multiple sclerosis lesionsSimon Licht-Mayer, Isabella Wimmer, Sarah Traffehn, et al.
Journal of the Neurological Sciences|February 7, 2018
CLIPPERS with longitudinally extensive transverse myelitis: Role of T versus B cellsDavid G Olmes, Imke Metz, De-Hyung Lee, et al.
Free Neuropathology|October 20, 2023
Serum neurofilament light chains in progressive multiple sclerosis patients treated with repeated cycles of high-dose intravenous steroidsLidia Stork, Michael Haupts, Niels Kruse, et al.
Case Reports in Neurological Medicine|December 21, 2016
Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to FingolimodTim Sinnecker, Jalal Othman, Marc Kühl, et al.
Neurology|June 24, 2018
Drug reaction with eosinophilia and systemic symptoms after daclizumab therapySebastian Rauer, Lidia Stork, Horst Urbach, et al.
Pageof 8